Hitiq (ASX:HIQ) said it expects up to AU$6.3 million in potential revenue from its agreement with US-based Shock Doctor, according to a June 13 filing with the Australian bourse.
On June 11, the company signed an agreement to design a mouthguard that integrates the company's Proteqt technology, with plans to produce 20,000 units this year and 100,000 units in 2026.
The non-conditional agreement is for five years with the option to be renewed for an additional five years. The product will be distributed in Australia and the UK, the filing said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。